Mechanisms of Resistance to KRASG12C Inhibitors
V Dunnett-Kane, P Nicola, F Blackhall, C Lindsay - Cancers, 2021 - mdpi.com
Simple Summary KRAS is a gene that is commonly mutated in cancer, especially in
pancreatic, lung and colorectal cancers. Despite its importance, scientists have for many …
pancreatic, lung and colorectal cancers. Despite its importance, scientists have for many …
Targeting KRAS in pancreatic cancer: new drugs on the horizon
SF Bannoura, MH Uddin, M Nagasaka, F Fazili… - Cancer and Metastasis …, 2021 - Springer
Abstract Kirsten Rat Sarcoma (KRAS) is a master oncogene involved in cellular proliferation
and survival and is the most commonly mutated oncogene in all cancers. Activating KRAS …
and survival and is the most commonly mutated oncogene in all cancers. Activating KRAS …
Urothelial tumorigenesis: a tale of divergent pathways
XR Wu - Nature Reviews Cancer, 2005 - nature.com
Urothelial carcinoma of the bladder is unique among epithelial carcinomas in its divergent
pathways of tumorigenesis. Low-grade papillary tumours rarely become muscle-invasive …
pathways of tumorigenesis. Low-grade papillary tumours rarely become muscle-invasive …
Development of farnesyl transferase inhibitors: a review
NMGM Appels, JH Beijnen, JHM Schellens - The oncologist, 2005 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Describe the potential mechanisms by which farnesyl transferases inhibit tumor growth …
Describe the potential mechanisms by which farnesyl transferases inhibit tumor growth …
[图书][B] Biomolecular action of ionizing radiation
S Lehnert - 2007 - taylorfrancis.com
Embracing the transformation of radiation sciences by the recent surge of developments in
molecular biology, this progressive text offers an up-to-date analysis of in vitro and in vivo …
molecular biology, this progressive text offers an up-to-date analysis of in vitro and in vivo …
The Rheb family of GTP-binding proteins
PJ Aspuria, F Tamanoi - Cellular signalling, 2004 - Elsevier
Rheb proteins represent a novel and unique family of the Ras superfamily GTP-binding
proteins that is conserved from yeast to human. Biochemical studies establish that they bind …
proteins that is conserved from yeast to human. Biochemical studies establish that they bind …
Benzophenone: A ubiquitous scaffold in medicinal chemistry
K Surana, B Chaudhary, M Diwaker, S Sharma - MedChemComm, 2018 - pubs.rsc.org
The benzophenone scaffold represents a ubiquitous structure in medicinal chemistry
because it is found in several naturally occurring molecules which exhibit a variety of …
because it is found in several naturally occurring molecules which exhibit a variety of …
Zinc metalloproteins as medicinal targets
AI Anzellotti, NP Farrell - Chemical Society Reviews, 2008 - pubs.rsc.org
Zinc bioinorganic chemistry has emphasized the role of the metal ion on the structure and
function of the protein. There is, more recently, an increasing appreciation of the role of zinc …
function of the protein. There is, more recently, an increasing appreciation of the role of zinc …
Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines
IA Kim, SS Bae, A Fernandes, JM Wu, RJ Muschel… - Cancer research, 2005 - AACR
Ras activation promotes the survival of tumor cells after DNA damage. To reverse this
survival advantage, Ras signaling has been targeted for inhibition. Other contributors to Ras …
survival advantage, Ras signaling has been targeted for inhibition. Other contributors to Ras …
Anti-cancer therapy: targeting the mevalonate pathway
KM Swanson, RJ Hohl - Current cancer drug targets, 2006 - ingentaconnect.com
The mevalonate pathway has become an important target for anti-cancer therapy.
Manipulation of this pathway results in alteration of malignant cell growth and survival in cell …
Manipulation of this pathway results in alteration of malignant cell growth and survival in cell …